Man Group PLC Syndax Pharmaceuticals Inc Transaction History
Man Group PLC
- $37.2 Billion
- Q1 2025
A detailed history of Man Group PLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Man Group PLC holds 134,136 shares of SNDX stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
134,136
Previous 121,539
10.36%
Holding current value
$1.5 Million
Previous $1.61 Million
2.62%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SNDX
# of Institutions
240Shares Held
101MCall Options Held
1.36MPut Options Held
618K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$95.1 Million8.82% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$88.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.87MShares$54.4 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.21MShares$47 Million5.73% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.01MShares$44.7 Million0.12% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $631M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...